Status:
WITHDRAWN
Mechanisms of Response to Diesel Exhaust in Subjects With Asthma
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Rutgers University
Conditions:
Asthma
Eligibility:
All Genders
18-55 years
Brief Summary
In a controlled exposure setting, the study's goal is to determine the acute effect of diesel exhaust (DE) inhalation on airway inflammation and hyperresponsiveness (AHR) in subjects with mild to mode...
Detailed Description
The investigators will also characterize selected polymorphisms in glutathione-S-transferase (GST) genes that have been implicated in susceptibility to air pollutants. Outcome measures will include lu...
Eligibility Criteria
Inclusion
- Subject is an adult male or female between 18 and 55 years of age inclusive.
- Subject must have a prior history of a physician's diagnosis of asthma with reversible airway obstruction (shown by a greater than 12% increase in FEV1 following bronchodilator; or a positive methacholine challenge done following the screening visit. If methacholine challenge is required for qualification, a physician will be on-site for the test. Subject's asthma has been stable for the past six months with no change in asthma therapy.
- The subject has been a non-smoker for the past year and should have less than a 10-pack year history.
- Subject must be free of other significant pulmonary diseases (i.e., cystic fibrosis, tuberculosis, interstitial lung disease and bronchopulmonary dysplasia.
- The subject must be capable of and willing to provide written informed consent.
- The subject is able to understand and comply with protocol requirements and timetables, instructions and protocol-stated restrictions.
- The subject has no significant DE exposure that would include occupations such as truck driver, heavy equipment operator and railroad maintenance.
- \-
Exclusion
- As a result of the medical interview, physical examination or screening investigations, the physician responsible considers the volunteer unfit for the study.
- The subject has received an investigational drug or participated in any other research trial within 30 days or five half-lives or twice the duration of the biological effect of any drug (whichever is longer) prior to the current study.
- Oral steroids within the last 6 months.
- Less than 12% FEV1 response to bronchodilator or negative methacholine challenge.
- Hospital admission for asthma in past 6 months.
- The subject has a history of alcohol or drug abuse within the last 5 years.
- The subject has history of hepatitis B, hepatitis C or HIV virus.
- The subject has a history of cardiovascular disease including hypertension or says yes to one of the cardiovascular risk questions on the screening questionnaire.
- The subject has a history of diabetes.
- The subject is pregnant or lactating.
- The subject has daily exposure to DE, i.e., trucking or heavy machine operators.
- \-
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01799746
Start Date
March 1 2013
End Date
December 31 2015
Last Update
April 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Airways Biology Initiative at Penn Presbyterian Medical Center
Philadephia, Pennsylvania, United States, 19104